id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-0268-0013,FDA,FDA-2015-D-0268,Guidance for Industry on Individual Patient Expanded Access Applications - Form FDA 3926,Other,Guidance,2016-06-03T04:00:00Z,2016,6,2016-06-03T04:00:00Z,,2025-01-04T22:22:27Z,,1,0,090000648200e1ee
FDA-2015-D-0268-0012,FDA,FDA-2015-D-0268,"Individual Patient Expanded Access Applications: Form FDA 3926; 
Guidance for Industry; Availability",Notice,Notice of Availability,2016-06-03T04:00:00Z,2016,6,2016-06-03T04:00:00Z,,2016-06-03T16:26:38Z,2016-13167,0,0,090000648200d4f8
FDA-2015-D-0268-0011,FDA,FDA-2015-D-0268,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Guidance for
Industry on Individual Patient Expanded Access Applications: Form
FDA 3926",Notice,30 Day Proposed Information Collection,2016-03-11T05:00:00Z,2016,3,2016-03-11T05:00:00Z,2016-04-12T03:59:59Z,2016-03-11T14:58:53Z,2016-05491,0,0,0900006481ebbfe3